Cargando…
BG-4, a novel anticancer peptide from bitter gourd (Momordica charantia), promotes apoptosis in human colon cancer cells
Momordica charantia is a perennial plant with reported health benefits. BG-4, a novel peptide from Momordica charantia, was isolated, purified and characterized. The trypsin inhibitory activity of BG-4 is 8.6 times higher than purified soybean trypsin inhibitor. The high trypsin inhibitory activity...
Autores principales: | Dia, Vermont P., Krishnan, Hari B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5024301/ https://www.ncbi.nlm.nih.gov/pubmed/27628414 http://dx.doi.org/10.1038/srep33532 |
Ejemplares similares
-
BG-4 from Bitter Gourd (Momordica charantia) Differentially Affects Inflammation In Vitro and In Vivo
por: Nieto-Veloza, Andrea, et al.
Publicado: (2019) -
An Update Review on the Anthelmintic Activity of Bitter Gourd, Momordica charantia
por: Poolperm, Sutthaya, et al.
Publicado: (2017) -
Analysis of the Complete Mitochondrial Genome of the Bitter Gourd (Momordica charantia)
por: Niu, Yu, et al.
Publicado: (2023) -
Effect of seed hydro-priming durations on germination and seedling growth of bitter gourd (Momordica charantia)
por: Adhikari, Binod, et al.
Publicado: (2021) -
Mapping of the Gynoecy in Bitter Gourd (Momordica charantia) Using RAD-Seq Analysis
por: Matsumura, Hideo, et al.
Publicado: (2014)